These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27144602)

  • 1. Start-ups: A sense of enterprise.
    Savage N
    Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
    [No Abstract]   [Full Text] [Related]  

  • 2. Q&A: Horst Domdey.
    Wald C
    Nature; 2016 May; 533(7601):S30-1. PubMed ID: 27144606
    [No Abstract]   [Full Text] [Related]  

  • 3. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 4. Commercializing biotechnology in the UK.
    Searle S; Graves B; Towler C
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976
    [No Abstract]   [Full Text] [Related]  

  • 5. How private-sector research is changing China.
    Murphy F
    Nature; 2018 Jan; 553(7688):S28-S30. PubMed ID: 29345661
    [No Abstract]   [Full Text] [Related]  

  • 6. Tech transfer fails to translate into startups.
    Lawrence S
    Nat Biotechnol; 2007 Jun; 25(6):616. PubMed ID: 17557089
    [No Abstract]   [Full Text] [Related]  

  • 7. Start up and succeed.
    Kaplan K
    Nature; 2009 Nov; 462(7272):530-1. PubMed ID: 20066758
    [No Abstract]   [Full Text] [Related]  

  • 8. Technology transfer: The leap to industry.
    Wapner J
    Nature; 2016 May; 533(7601):S13-5. PubMed ID: 27144603
    [No Abstract]   [Full Text] [Related]  

  • 9. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 10. Innovation: Bridging the market gap.
    Zappe H
    Nature; 2013 Sep; 501(7468):483-5. PubMed ID: 24073448
    [No Abstract]   [Full Text] [Related]  

  • 11. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 12. Calling for entrepreneurs: London.
    Smaglik P
    Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
    [No Abstract]   [Full Text] [Related]  

  • 13. China: Building an innovator.
    Phillips N
    Nature; 2016 May; 533(7601):S32-3. PubMed ID: 27144607
    [No Abstract]   [Full Text] [Related]  

  • 14. Germany's attitude to start-up firms is undergoing profound change.
    Curry A
    Nature; 2019 Mar; 567(7749):S64-S65. PubMed ID: 30918388
    [No Abstract]   [Full Text] [Related]  

  • 15. France's research minister lays out his priorities.
    Butler D
    Nature; 2016 May; 533(7602):157-8. PubMed ID: 27172026
    [No Abstract]   [Full Text] [Related]  

  • 16. The technology trap.
    Gewin V
    Nature; 2005 Oct; 437(7061):948-9. PubMed ID: 16222269
    [No Abstract]   [Full Text] [Related]  

  • 17. U2B: a new model for technology transfer.
    Gross CM
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE31-2. PubMed ID: 12874975
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech's wellspring-a survey of the health of the private sector in 2015.
    Huggett B
    Nat Biotechnol; 2016 Jun; 34(6):608-15. PubMed ID: 27281417
    [No Abstract]   [Full Text] [Related]  

  • 19. Q&A: Helga Nowotny.
    Wald C
    Nature; 2016 May; 533(7601):S47. PubMed ID: 27144610
    [No Abstract]   [Full Text] [Related]  

  • 20. Papers to patents.
    Arora A; Belenzon S; Patacconi A
    Nature; 2017 Dec; 552(7683):S10. PubMed ID: 29219977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.